AllianceBernstein’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-123,907
| Closed | -$26.9M | – | 3525 |
|
|
2021
Q1 | $26.9M | Buy |
123,907
+61,528
| +99% | +$11.6M | 0.01% | 821 |
|
|
2020
Q4 | $7.2M | Buy |
62,379
+1,490
| +2% | +$167K | ﹤0.01% | 1300 |
|
|
2020
Q3 | $5.93M | Buy |
60,889
+15,901
| +35% | +$1.83M | ﹤0.01% | 1262 |
|
|
2020
Q2 | $5.52M | Buy |
44,988
+1,775
| +4% | +$201K | ﹤0.01% | 1273 |
|
|
2020
Q1 | $3.78M | Sell |
43,213
-184,788
| -81% | -$19.6M | ﹤0.01% | 1315 |
|
|
2019
Q4 | $23.8M | Buy |
228,001
+7,939
| +4% | +$890K | 0.01% | 765 |
|
|
2019
Q3 | $25.3M | Sell |
220,062
-86,623
| -28% | -$13.1M | 0.02% | 715 |
|
|
2019
Q2 | $52.9M | Sell |
306,685
-14,958
| -5% | -$2.59M | 0.03% | 520 |
|
|
2019
Q1 | $54.2M | Sell |
321,643
-31,784
| -9% | -$4.73M | 0.04% | 500 |
|
|
2018
Q4 | $34.4M | Buy |
353,427
+8,850
| +3% | +$1.16M | 0.03% | 596 |
|
|
2018
Q3 | $59.5M | Buy |
344,577
+34,010
| +11% | +$4.9M | 0.04% | 455 |
|
|
2018
Q2 | $43.3M | Buy |
310,567
+1,824
| +0.6% | +$259K | 0.03% | 563 |
|
|
2018
Q1 | $34.8M | Sell |
308,743
-23,530
| -7% | -$2.96M | 0.03% | 602 |
|
|
2017
Q4 | $43.9M | Buy |
332,273
+50,780
| +18% | +$5.97M | 0.03% | 526 |
|
|
2017
Q3 | $28.6M | Sell |
281,493
-36,463
| -11% | -$3.91M | 0.02% | 654 |
|
|
2017
Q2 | $31.9M | Buy |
317,956
+31,481
| +11% | +$3.39M | 0.02% | 610 |
|
|
2017
Q1 | $34.6M | Buy |
286,475
+12,519
| +5% | +$1.54M | 0.03% | 560 |
|
|
2016
Q4 | $30.6M | Buy |
273,956
+20,589
| +8% | +$2.48M | 0.03% | 591 |
|
|
2016
Q3 | $33.6M | Sell |
253,367
-72,110
| -22% | -$6.89M | 0.03% | 549 |
|
|
2016
Q2 | $29.8M | Sell |
325,477
-31,357
| -9% | -$2.64M | 0.03% | 565 |
|
|
2016
Q1 | $25.7M | Sell |
356,834
-58,420
| -14% | -$3.21M | 0.02% | 611 |
|
|
2015
Q4 | $28.8M | Buy |
415,254
+69,133
| +20% | +$5.63M | 0.02% | 583 |
|
|
2015
Q3 | $31.6M | Sell |
346,121
-72,743
| -17% | -$8.09M | 0.03% | 545 |
|
|
2015
Q2 | $51.5M | Sell |
418,864
-34,416
| -8% | -$3.9M | 0.04% | 467 |
|
|
2015
Q1 | $41.3M | Sell |
453,280
-53,445
| -11% | -$4.34M | 0.03% | 527 |
|
|
2014
Q4 | $34.3M | Buy |
506,725
+35,591
| +8% | +$2.6M | 0.03% | 564 |
|
|
2014
Q3 | $38.1M | Buy |
471,134
+97,694
| +26% | +$8.64M | 0.03% | 538 |
|
|
2014
Q2 | $40.1M | Buy |
373,440
+91,600
| +33% | +$6.37M | 0.03% | 521 |
|
|
2014
Q1 | $16.7M | Buy |
+281,840
| New | +$16.8M | 0.01% | 710 |
|
Other funds holding GWPH
AllianceBernstein's GWPH Position: Q2 2021 in Review
AllianceBernstein sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 123,907 shares — an estimated $26.9M sold.
AllianceBernstein first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $59.5M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- AllianceBernstein reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- AllianceBernstein sold 123,907 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $26.9M.
- AllianceBernstein first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
- AllianceBernstein's GW Pharmaceuticals Plc American Depositary Shares position peaked at $59.5M in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.